» Authors » Salvatore Annunziata

Salvatore Annunziata

Explore the profile of Salvatore Annunziata including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 94
Citations 926
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maccora D, Guerreri M, Malafronte R, DAlo F, Hohaus S, De Summa M, et al.
Diagnostics (Basel) . 2025 Feb; 15(4). PMID: 40002583
: Patients with low tumour burden follicular lymphoma (FL) are managed with an initial watchful waiting (WW) approach. The way to better predict the time-to-treatment (TTT) is still under investigation...
2.
Triumbari E, Morland D, Gatta R, Boldrini L, De Summa M, Chiesa S, et al.
Ann Hematol . 2025 Jan; 104(1):641-651. PMID: 39808225
In a previous preliminary study, radiomic features from the largest and the hottest lesion in baseline F-FDG PET/CT (bPET/CT) of classical Hodgkin's Lymphoma (cHL) predicted early response-to-treatment and prognosis. Aim...
3.
Pizzuto D, Castello A, Chiappetta M, Castellani M, Annunziata S, Campanella A, et al.
Mol Diagn Ther . 2025 Jan; 29(2):239-248. PMID: 39777612
Objectives: To investigate whether 18F-fluorodeoxyglucose positron emission tomography-computed tomography ([F]F-FDG PET/CT) metabolic parameters were associated with histology and to assess their prognostic role in patients with thymic lesions. Patients And...
4.
Albano D, Ravanelli M, Durmo R, Versari A, Filice A, Rizzo A, et al.
Front Med (Lausanne) . 2025 Jan; 11:1515040. PMID: 39744526
2-deoxy-2-[F]-fluoro-D-glucose (2-[F]FDG) positron emission tomography/computed tomography (PET/CT) plays a crucial role in the management of lymphoma in different settings, such as staging disease, assessing response to therapy, predicting prognosis, and...
5.
Galli E, Guarneri A, Sora F, Viscovo M, Pansini I, Maiolo E, et al.
Hematol Oncol . 2024 Dec; 43(1):e70029. PMID: 39716447
Disease burden is a critical determinant of outcomes in CAR-T therapy for B-cell lymphomas, and one of the most widely used techniques for its assessment is Total Metabolic Tumor Volume...
6.
Mahagna A, Annunziata S, Torriani C, Jannelli E, Mascia B, Montagna A, et al.
Healthcare (Basel) . 2024 Oct; 12(19). PMID: 39408188
Background: Hemophilia type A and B is associated with spontaneous bleeding in muscle tissues and joints. Acute hemarthrosis, representing 70-80% of all bleedings in severe hemophilia patients, is extremely painful....
7.
Pasta G, Annunziata S, Ruggieri R, Abruzzi D, Arrigoni P, Jannelli E, et al.
Healthcare (Basel) . 2024 Sep; 12(17). PMID: 39273799
This study presents a detailed case analysis of a 40-year-old male patient with hemophilia A and severe chronic elbow arthropathy, exploring the surgical challenges and outcomes within the context of...
8.
Rizzo A, Albano D, Elisei F, Racca M, Dondi F, Annunziata S, et al.
Diagnostics (Basel) . 2024 Jul; 14(14). PMID: 39061653
Background: Recent studies have suggested using positron emission tomography/computed tomography (PET/CT) with prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals for the detection of salivary gland malignancies (SGM), particularly adenoid-cystic carcinoma (ACC). Methods:...
9.
Rizzo A, Albano D, Dondi F, Cioffi M, Muoio B, Annunziata S, et al.
Front Med (Lausanne) . 2024 Apr; 11:1381863. PMID: 38590320
Background: Several recent studies have proposed the possible application of positron emission tomography/computed tomography (PET/CT) administering radiolabelled fibroblast-activation protein (FAP) inhibitors for various forms of thyroid cancer (TC), including differentiated...
10.
Collarino A, Feudo V, Pasciuto T, Florit A, Pfaehler E, De Summa M, et al.
J Nucl Med . 2024 Mar; 65(6):962-970. PMID: 38548352
This study investigated whether radiomic features extracted from pretreatment [F]FDG PET could improve the prediction of both histopathologic tumor response and survival in patients with locally advanced cervical cancer (LACC)...